Cargando…
Antitumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318711/ https://www.ncbi.nlm.nih.gov/pubmed/25306900 http://dx.doi.org/10.1038/leu.2014.300 |
| _version_ | 1782355874425077760 |
|---|---|
| author | Suzuki, Rikio Hidehsima, Teru Mimura, Naoya Minami, Jiro Ohguchi, Hiroto Kikuchi, Shohei Yoshida, Yasuhiro Gorgun, Gullu Cirstea, Diana Cottini, Francesca Jakubikova, Jana Tai, Yu-Tzu Chauhan, Dharminder Richardson, Paul G. Munshi, Nikhil Utsugi, Teruhiro Anderson, Kenneth C. |
| author_facet | Suzuki, Rikio Hidehsima, Teru Mimura, Naoya Minami, Jiro Ohguchi, Hiroto Kikuchi, Shohei Yoshida, Yasuhiro Gorgun, Gullu Cirstea, Diana Cottini, Francesca Jakubikova, Jana Tai, Yu-Tzu Chauhan, Dharminder Richardson, Paul G. Munshi, Nikhil Utsugi, Teruhiro Anderson, Kenneth C. |
| author_sort | Suzuki, Rikio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4318711 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-43187112015-08-01 Antitumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma Suzuki, Rikio Hidehsima, Teru Mimura, Naoya Minami, Jiro Ohguchi, Hiroto Kikuchi, Shohei Yoshida, Yasuhiro Gorgun, Gullu Cirstea, Diana Cottini, Francesca Jakubikova, Jana Tai, Yu-Tzu Chauhan, Dharminder Richardson, Paul G. Munshi, Nikhil Utsugi, Teruhiro Anderson, Kenneth C. Leukemia Article 2014-10-13 2015-02 /pmc/articles/PMC4318711/ /pubmed/25306900 http://dx.doi.org/10.1038/leu.2014.300 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
| spellingShingle | Article Suzuki, Rikio Hidehsima, Teru Mimura, Naoya Minami, Jiro Ohguchi, Hiroto Kikuchi, Shohei Yoshida, Yasuhiro Gorgun, Gullu Cirstea, Diana Cottini, Francesca Jakubikova, Jana Tai, Yu-Tzu Chauhan, Dharminder Richardson, Paul G. Munshi, Nikhil Utsugi, Teruhiro Anderson, Kenneth C. Antitumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma |
| title | Antitumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma |
| title_full | Antitumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma |
| title_fullStr | Antitumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma |
| title_full_unstemmed | Antitumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma |
| title_short | Antitumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma |
| title_sort | antitumor activities of selective hsp90α/β inhibitor, tas-116, in combination with bortezomib in multiple myeloma |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318711/ https://www.ncbi.nlm.nih.gov/pubmed/25306900 http://dx.doi.org/10.1038/leu.2014.300 |
| work_keys_str_mv | AT suzukirikio antitumoractivitiesofselectivehsp90abinhibitortas116incombinationwithbortezomibinmultiplemyeloma AT hidehsimateru antitumoractivitiesofselectivehsp90abinhibitortas116incombinationwithbortezomibinmultiplemyeloma AT mimuranaoya antitumoractivitiesofselectivehsp90abinhibitortas116incombinationwithbortezomibinmultiplemyeloma AT minamijiro antitumoractivitiesofselectivehsp90abinhibitortas116incombinationwithbortezomibinmultiplemyeloma AT ohguchihiroto antitumoractivitiesofselectivehsp90abinhibitortas116incombinationwithbortezomibinmultiplemyeloma AT kikuchishohei antitumoractivitiesofselectivehsp90abinhibitortas116incombinationwithbortezomibinmultiplemyeloma AT yoshidayasuhiro antitumoractivitiesofselectivehsp90abinhibitortas116incombinationwithbortezomibinmultiplemyeloma AT gorgungullu antitumoractivitiesofselectivehsp90abinhibitortas116incombinationwithbortezomibinmultiplemyeloma AT cirsteadiana antitumoractivitiesofselectivehsp90abinhibitortas116incombinationwithbortezomibinmultiplemyeloma AT cottinifrancesca antitumoractivitiesofselectivehsp90abinhibitortas116incombinationwithbortezomibinmultiplemyeloma AT jakubikovajana antitumoractivitiesofselectivehsp90abinhibitortas116incombinationwithbortezomibinmultiplemyeloma AT taiyutzu antitumoractivitiesofselectivehsp90abinhibitortas116incombinationwithbortezomibinmultiplemyeloma AT chauhandharminder antitumoractivitiesofselectivehsp90abinhibitortas116incombinationwithbortezomibinmultiplemyeloma AT richardsonpaulg antitumoractivitiesofselectivehsp90abinhibitortas116incombinationwithbortezomibinmultiplemyeloma AT munshinikhil antitumoractivitiesofselectivehsp90abinhibitortas116incombinationwithbortezomibinmultiplemyeloma AT utsugiteruhiro antitumoractivitiesofselectivehsp90abinhibitortas116incombinationwithbortezomibinmultiplemyeloma AT andersonkennethc antitumoractivitiesofselectivehsp90abinhibitortas116incombinationwithbortezomibinmultiplemyeloma |